Author:
Fusi Fabio,Trezza Alfonso,Sgaragli Giampietro,Spiga Ottavia,Saponara Simona,Bova Sergio
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference51 articles.
1. Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM. Receptor-binding properties in vitro and in vivo of ritanserin: a very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 1985;27:600–11.
2. https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=biology&ligandId=97. Accessed 9 Mar 2019.
3. Kriston L, von Wolff A, Westphal A, Hölzel LP, Härter M. Efficacy and acceptability of acute treatments for persistent depressive disorder: a network meta-analysis. Depress Anxiety 2014;31:621–30.
4. Singh SP, Singh V, Kar N, Chan K. Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis [published correction appears in Br J Psychiatry. 2011;198:159]. Br J Psychiatry. 2010;197:174–9.
5. Cornish JW, Maany I, Fudala PJ, Ehrman RN, Robbins SJ, O’Brien CP. A randomized, double-blind, placebo-controlled study of ritanserin pharmacotherapy for cocaine dependence. Drug Alcohol Depend. 2001;61:183–9.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献